✦ LIBER ✦

Defining the response to interferon-β in relapsing-remitting multiple sclerosis patients

✍ Scribed by Jordi Río; Carlos Nos; Mar Tintoré; Nieves Téllez; Ingrid Galán; Raúl Pelayo; Manuel Comabella; Xavier Montalban

Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 122 KB
Volume: 59
Category: Article
ISSN: 0364-5134
DOI: 10.1002/ana.20740

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Defining interferon β response status in

Defining interferon β response status in multiple sclerosis patients

✍ Richard A. Rudick; Jar-Chi Lee; Jack Simon; Richard M. Ransohoff; Elizabeth Fish 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 166 KB

Interferon-β treatment and the natural h

Interferon-β treatment and the natural history of relapsing-remitting multiple sclerosis

✍ Marcus Koch; Jop Mostert; Jacques De Keyser; Helen Tremlett; Graziella Filippini 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 51 KB 👁 1 views

Incidence of exacerbations in the first

Incidence of exacerbations in the first 90 days of treatment with recombinant human interferon β-1b in patients with relapsing-remitting multiple sclerosis

✍ Dr. Omar A. Khan; J. Richard Hebel 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 230 KB 👁 1 views

Contrasting responses to interferon β-1b

Contrasting responses to interferon β-1b treatment in relapsing-remitting multiple sclerosis: Does baseline interleukin-12p35 messenger RNA predict the efficacy of treatment?

✍ A. H. H. Van Boxel-Dezaire; S. C. J. Van Trigt-Hoff; J. Killestein; H. M. Schrij 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 182 KB 👁 1 views

Assessment of different treatment failur

Assessment of different treatment failure criteria in a cohort of relapsing–remitting multiple sclerosis patients treated with interferon β: Implications for clinical trials

✍ Jordi Río; Carlos Nos; Mar Tintoré; Cecilia Borrás; Ingrid Galán; Manuel Comabel 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB 👁 2 views

Magnetic resonance imaging results of th

Magnetic resonance imaging results of the PRISMS trial: A randomized, double-blind, placebo-controlled study of interferon-β1a in relapsing-remitting multiple sclerosis

✍ David K. B. Li; Donald W. Paty 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 164 KB 👁 2 views

The PRISMS (Prevention of Relapses and Disability by Interferon-␤1a Subcutaneously in Multiple Sclerosis) trial was a doubleblind, randomized, multicenter, phase III, placebo-controlled study of interferon-␤1a in 560 patients from 22 centers in 9 countries with clinically definite or laboratory-supp